Vai offline con l'app Player FM !
Episode 49. Updates on Low-Risk MDS with Dr. Maximilian Stahl
Manage episode 434157435 series 3369804
In this episode, we discuss updates on low-risk MDS with Dr. Maximilian Stahl with a focus on imetelstat and luspatercept.
Here are the trials we discussed:
1. IWG 2019 response criteria
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042664/
2. MEDALIST trial: Luspatercept
3. COMMANDS trial : Luspatercept
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00874-7/abstract
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00203-5/abstract
4. IMerge trial: Imetelstat
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01724-5/abstract
57 episodi
Manage episode 434157435 series 3369804
In this episode, we discuss updates on low-risk MDS with Dr. Maximilian Stahl with a focus on imetelstat and luspatercept.
Here are the trials we discussed:
1. IWG 2019 response criteria
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042664/
2. MEDALIST trial: Luspatercept
3. COMMANDS trial : Luspatercept
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00874-7/abstract
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00203-5/abstract
4. IMerge trial: Imetelstat
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01724-5/abstract
57 episodi
Tutti gli episodi
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.